StratDeck

Two stocks in Healthcare

Fresenius Medical Care vs Zealand Pharma A/S: profit, growth, debt and price compared

Fresenius Medical Care and Zealand Pharma A/S are each stronger on 3 of 6 figures: Fresenius Medical Care on sales growth, price for its expected profit and price trend; Zealand Pharma A/S on profit margin, debt and analysts' view.

Figures as of 18 November 2026Yahoo Finance
Explore Fresenius Medical Care's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Fresenius Medical Care and Zealand Pharma A/S side by side
Fresenius Medical CareFME.DEZealand Pharma A/SZEAL.CO
Net margin4.2%Stronger: 67.2%
Revenue growth, past yearStronger: +1.10%−92.00%
Debt to equity79.2%Stronger: 2.8%
Forward P/EStronger: 10.1×30.7×
Dividend yield3.74%—
AnalystsHold · 17Stronger: Buy · 12
From its 200-day averageStronger: −3.1%−28.0%

Share price over the past year

  • Fresenius Medical Care−2.7%
  • Zealand Pharma A/S−59.4%

20 Nov 202518 Nov 2026

Fresenius Medical Care or Zealand Pharma A/S: which is stronger?

  • ZEAL.CO

    Which is more profitable?

    Zealand Pharma A/S keeps more of each sale as profit: 67.2% against 4.2%.

  • FME.DE

    Which is growing its sales faster?

    Fresenius Medical Care is growing its sales faster: +1.10% over the past year, against −92.00%.

  • ZEAL.CO

    Which has borrowed less?

    Zealand Pharma A/S has borrowed less: its debt is 2.8% of what its shareholders own, against 79.2% for Fresenius Medical Care.

  • FME.DE

    Which costs less for the profit it is expected to make?

    Fresenius Medical Care costs less for the profit it is expected to make: 10.1× its forward earnings, against 30.7×.

  • Which pays more in dividends?

    Fresenius Medical Care pays 3.74% a year in dividends for what a share costs, where Zealand Pharma A/S pays none.

  • ZEAL.CO

    Which do analysts rate higher?

    Analysts are warmer on Zealand Pharma A/S: Buy, against Hold for Fresenius Medical Care.

  • FME.DE

    Which is in the stronger price trend?

    Fresenius Medical Care's price is in the stronger trend: 3.1% below its 200-day average, against 28.0% below.

What each company does

FME.DEFresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

Reports results on 23 February 2027

ZEAL.COZealand Pharma A/S

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

Reports results on 25 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.